BioCentury | May 2, 2016
Company News

Aviragen, HealthCare Royalty Partners deal

...in Japan to treat and prevent influenza A and B infection. Daiichi and Aviragen (formerly Biota Holdings Ltd....
BioCentury | Aug 19, 2013
Clinical News

Civacir: Phase III started

...its 2007 acquisition of the Nabi Biologics Group of Nabi Biopharmaceuticals , which merged with Biota Holdings Ltd....
BioCentury | Dec 3, 2012
Clinical News

Inavir laninamivir regulatory update

...adults and children (see BioCentury, Sept. 20, 2010). Daiichi has Japanese rights to Inavir from Biota Holdings Ltd....
BioCentury | Nov 12, 2012
Company News

Biota, Nabi deal

...held by Nabi when the deal is completed (see BioCentury, April 30 & Sept. 24). Biota Holdings Ltd....
BioCentury | Oct 29, 2012
Company News

Biota, Nabi deal

...shares in exchange for 0.669 new Nabi shares (see BioCentury, April 30 & Sept. 24). Biota Holdings Ltd....
BioCentury | Oct 22, 2012
Clinical News

NicVax: Preliminary Phase II data

...shareholders meeting, during which shareholders were to vote on the proposed merger of Nabi and Biota Holdings Ltd....
BioCentury | Oct 1, 2012
Finance

3Q Stock Wrap-Up: Back in black

...4Q12 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) GALNS Mucopolysaccharidosis IVA (MPS-IVA, Morquio's syndrome) Ph III data 4Q12 Biota Holdings Ltd....
BioCentury | Oct 1, 2012
Company News

Nabi infectious, neurology news

...shareholders meeting, during which shareholders were to vote on the proposed merger of Nabi and Biota Holdings Ltd....
BioCentury | Sep 24, 2012
Company News

Biota, Nabi deal

...the proposed merger. Mangrove controls about a 4% stake in Nabi (see BioCentury, Aug. 20). Biota Holdings Ltd....
BioCentury | Aug 27, 2012
Clinical News

Inavir laninamivir: Phase III data

...to Nabi shareholders recommending that shareholders vote against the proposed merger (see BioCentury, Aug. 20). Biota Holdings Ltd....
Items per page:
1 - 10 of 230
BioCentury | May 2, 2016
Company News

Aviragen, HealthCare Royalty Partners deal

...in Japan to treat and prevent influenza A and B infection. Daiichi and Aviragen (formerly Biota Holdings Ltd....
BioCentury | Aug 19, 2013
Clinical News

Civacir: Phase III started

...its 2007 acquisition of the Nabi Biologics Group of Nabi Biopharmaceuticals , which merged with Biota Holdings Ltd....
BioCentury | Dec 3, 2012
Clinical News

Inavir laninamivir regulatory update

...adults and children (see BioCentury, Sept. 20, 2010). Daiichi has Japanese rights to Inavir from Biota Holdings Ltd....
BioCentury | Nov 12, 2012
Company News

Biota, Nabi deal

...held by Nabi when the deal is completed (see BioCentury, April 30 & Sept. 24). Biota Holdings Ltd....
BioCentury | Oct 29, 2012
Company News

Biota, Nabi deal

...shares in exchange for 0.669 new Nabi shares (see BioCentury, April 30 & Sept. 24). Biota Holdings Ltd....
BioCentury | Oct 22, 2012
Clinical News

NicVax: Preliminary Phase II data

...shareholders meeting, during which shareholders were to vote on the proposed merger of Nabi and Biota Holdings Ltd....
BioCentury | Oct 1, 2012
Finance

3Q Stock Wrap-Up: Back in black

...4Q12 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) GALNS Mucopolysaccharidosis IVA (MPS-IVA, Morquio's syndrome) Ph III data 4Q12 Biota Holdings Ltd....
BioCentury | Oct 1, 2012
Company News

Nabi infectious, neurology news

...shareholders meeting, during which shareholders were to vote on the proposed merger of Nabi and Biota Holdings Ltd....
BioCentury | Sep 24, 2012
Company News

Biota, Nabi deal

...the proposed merger. Mangrove controls about a 4% stake in Nabi (see BioCentury, Aug. 20). Biota Holdings Ltd....
BioCentury | Aug 27, 2012
Clinical News

Inavir laninamivir: Phase III data

...to Nabi shareholders recommending that shareholders vote against the proposed merger (see BioCentury, Aug. 20). Biota Holdings Ltd....
Items per page:
1 - 10 of 230